Linden Capital Partners, a Chicago-based private equity firm focused on the healthcare industry, today announced that it has signed a definitive agreement to make a majority investment in Aspirion, which is engaged in technology-enabled healthcare revenue cycle management. Following the transaction, the company’s management team and Aquiline Capital Partners, a private investment firm based in New York and London, will remain investors in the company.
Aspirion’s product suite is centered on complex claims, an umbrella category for third party liability claims related to non-traditional payors, and revenue integrity, which addresses clinically complex claims with traditional medical payors. Read more.
